Merit Medical Systems Inc (MMSI)
84.40
-1.13
(-1.32%)
USD |
NASDAQ |
Jul 08, 16:00
84.40
0.00 (0.00%)
After-Hours: 17:24
Merit Medical Systems SG&A Expense (TTM): 377.96M for March 31, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 377.96M |
December 31, 2023 | 373.68M |
September 30, 2023 | 361.17M |
June 30, 2023 | 364.09M |
March 31, 2023 | 348.65M |
December 31, 2022 | 342.52M |
September 30, 2022 | 335.91M |
June 30, 2022 | 332.60M |
March 31, 2022 | 338.68M |
December 31, 2021 | 335.69M |
September 30, 2021 | 339.00M |
June 30, 2021 | 324.74M |
March 31, 2021 | 299.94M |
December 31, 2020 | 297.72M |
September 30, 2020 | 299.88M |
June 30, 2020 | 314.60M |
March 31, 2020 | 327.81M |
December 31, 2019 | 327.27M |
September 30, 2019 | 320.81M |
June 30, 2019 | 300.26M |
March 31, 2019 | 289.38M |
December 31, 2018 | 276.02M |
September 30, 2018 | 259.63M |
June 30, 2018 | 247.96M |
March 31, 2018 | 236.28M |
Date | Value |
---|---|
December 31, 2017 | 229.13M |
September 30, 2017 | 215.74M |
June 30, 2017 | 214.22M |
March 31, 2017 | 200.46M |
December 31, 2016 | 184.40M |
September 30, 2016 | 179.50M |
June 30, 2016 | 165.50M |
March 31, 2016 | 161.17M |
December 31, 2015 | 156.35M |
September 30, 2015 | 151.62M |
June 30, 2015 | 148.75M |
March 31, 2015 | 148.02M |
December 31, 2014 | 147.89M |
September 30, 2014 | 145.32M |
June 30, 2014 | 140.34M |
March 31, 2014 | 133.31M |
December 31, 2013 | 128.68M |
September 30, 2013 | 128.50M |
June 30, 2013 | 126.03M |
March 31, 2013 | 124.69M |
December 31, 2012 | 122.11M |
September 30, 2012 | 116.67M |
June 30, 2012 | 113.49M |
March 31, 2012 | 109.46M |
December 31, 2011 | 104.50M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
297.72M
Minimum
Dec 2020
377.96M
Maximum
Mar 2024
334.88M
Average
335.69M
Median
Dec 2021
SG&A Expense (TTM) Benchmarks
Boston Scientific Corp | 5.339B |
Becton Dickinson & Co | 4.734B |
ResMed Inc | 915.63M |
Stryker Corp | 7.188B |
Perspective Therapeutics Inc | 19.11M |